The Efficacy and Safety of BAT8001 Injection for the Treatment of HER2-positive Advanced Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: HER2-positive Advanced Breast Cancer
Interventions: BIOLOGICAL: BAT8001 for injection|DRUG: Lapatinib|DRUG: Capecitabine
Sponsor: Bio-Thera Solutions